Currently engaged in her internship at the laboratory of Prof. Massimo Caruso, co-project leader of the Replica project, Chiara Giardina, thanks to the work conducted in the laboratories of CoEHAR in Catania, managed to participate in and obtain the KAC scholarship.
The Royal College of Physicians has assessed the available evidence on the use of e-cigarettes, from health effects to the issue of youth vaping, publishing a report with over 50 recommendations. It concluded that e-cigarettes represent a valuable aid in smoking cessation, but that much more can and should be done to reduce their appeal, availability and affordability to people who do not smoke, including children and young people, and reduce environmental harms.
According to the studies, “CoEHAR research in patients with COPD patients, asthma, high blood pressure, schizophrenia show clear benefits with objective evidence for harm reversal after switching from smoking.. and also showed that lung function and respiratory symptoms and muco-ciliary clearance improve after switching from smoking to vaping”.
Jeffrey Zamora, President of Asovape Costa Rica, President of ARDT Iberoamerica and Veritas's project leader, said: "We are using an innovative platform with a 2-step verification process where people will enroll in the study. After registering on the website, participants will be asked to provide information about the devices used, frequency of use, age of initiation, flavor preferences, motivations, and any cigarette consumption or experimentation. They will also complete the Respiratory Symptom Experience Scale, a validated scale that asks subjects to rate the frequency with which they had experienced any respiratory symptoms".
The MAGNIFICAT study, strongly advocated by Prof. Riccardo Polosa, will evaluate the effects of the combined use of conventional cigarettes and electronic cigarettes on human health, quantifying this impact by collecting samples, researching and describing the core of different levels of dual use on exposure to toxic substances and harm reduction, and using specific biomarkers, clinical endpoints, and behavioral correlations
The data from these works as a whole can be used to assess the impact in terms of risk/benefit ratio of the regular use of combustion-free products, assisting the efforts of public health authorities in encouraging smokers to quit, especially those who perceive their smoke-damaged smile as a barrier to personal health or work and social relationships.
The study has been designed with the help of experts from Germany, UK, Italy, Poland, Moldova, and Indonesia. SMILE study is being conducted in four dental clinics across four different countries (Italy, Poland, Moldova, and Indonesia). Volunteer enrollment was completed in August 2023 and results will be expected to be available in 2025.
On Tuesday, February 20th, the MAGNIFICAT Project, coordinated by CoEHAR, hosted a pivotal workshop in Warsaw, Poland, to bring together all partners involved in in-depth discussions and hands-on exercises focusing…
Data confirms that there is high certainty that nicotine electronic cigarettes increases quit rates compared to nicotine replacement therapy.
The CoEHAR Council (made up of 71 of the 95 members of the Center of Excellence of the University of Catania), meeting in an online session, reconfirmed their trust in…
We will send you direct emails, without intermediary services, you can withdraw in time by replying directly to the newsletter
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.